Colony Stimulating Factor 1 Receptor
CSF1RgeneCSF1R drives monocyte/macrophage recruitment and survival in atherosclerotic plaque inflammation.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleMacrophage recruitment and activation; plaque inflammation.
Druggability
DruggableYes
Known drugs / candidates21
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000182578
Type I vs non-Type I discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I30
C — non-Type-I63
A — assay feasibility52
E — evidence strength24
T1DI (composite)4
Specificity differential (R−C)-33
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
No non-Type-I axis evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Integrative analysis of DNA methylation and gene expression reveals key molecular signatures in acute myocardial infarction.Clinical epigenetics · 2022 · PMID 35346355 · doi